The blood glucose monitoring devices market has witnessed significant advancements and growth, driven by the increasing ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today provided an update on ...

RHHBY's Accu-Chek Smartguide will provide several predictive features aimed at enhancing patient safety. However, the device ...

(Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by ...

Abbott (NYSE: ABT) today announced U.S. availability of Lingo™, the company's first continuous glucose monitoring system available without a prescription. The Lingo system includes a biosensor and a ...

Roche will roll out its Accu-Chek Smartguide in the Netherlands, Switzerland and Germany. The company hopes to stand out from competitors with features to predict hypoglycemia.

TRIB announces updates on its European patented process. The company aims to use this process to improve the functionality of ...

Trinity Biotech intends to use this breakthrough process to stabilize and improve the functionality of its glucose biosensor ...

A small new study suggests that time-restricted eating could help improve blood sugar control in some people, thus ...

Experts say restricting our eating window to an eight-hour period improved blood glucose control and could could boost all ...